Valeant pays $166mm plus earn-outs for Synergetics USA
Executive Summary
Valeant Pharmaceuticals International Inc. is buying public device firm Synergetics USA Inc. for $6.50 per share (a 50% premium) in cash, or $166.2mm, plus potential earn-outs.
Deal Industry
- Medical Devices
-
Medical Devices
- Consumables, Central Supplies
- Infusion Therapy Equipment and Supplies
- Laser
- Radiofrequency Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Includes Earnout
- Payment Includes Cash
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice